Abstract:Purpose The purpose of this paper is to exploit the effect of equity financing constraints on the firm’s investment in research and development (R&D) by utilizing a quasi-experiment in China. Design/methodology/approach A difference-in-difference identification strategy is employed to test the treatment effect of the IPO suspension in China. For robustness testing, the authors incorporate cross-sectional variation in external financial dependence to identify the different influences an IPO suspension has on R&D investments for firms across multiple industries through the difference-in-difference-in-difference approach and the authors also adopt a matching approach to check the parallel trend assumption. Moreover, the authors introduce a placebo test to further verify the empirical results. Findings Through the empirical analysis, the authors find that the firms subjecting to the IPO suspension are more likely to reduce their investments in R&D than those not affected by the IPO suspension. Besides, the negative effect of equity financing constraints on R&D investments is concentrated on external financial dependent industries. The firms in industries with larger external financial dependence tend to decrease more in their R&D expenditures when they experience the equity financing constraints. Research limitations/implications This paper provides a new negative evidence on equity financing constraints on R&D investments link so that contributes to the debate about the effect of the financing constraints on R&D investments. Practical implications The study provides a meaningful suggestion for governments to diminish the frictions in the financial market and to improve enterprises’ public financing circumstances by finding that equity financing constraints have negative impacts on firms’ R&D investments. Originality/value There are some apprehensions around previous empirical studies investigating the impact of financing constraints on R&D investments as the existing literature is unable to provide an unambiguous method to exactly distinguish and measure the degree of financing constraints the firms confronting with. This paper solves this problem by first utilizing an IPO suspension in China as a quasi-experiment to examine the effect of equity financing constraints. Therefore, it gives insight to solve the problem of measuring financing constraints in future researches.

Working capital management of IPO firms

Internal Capital Allocation in IPOs and Corporate Innovation: the Moderating Role of Political Connections

Initial Public Offering, Corporate Innovation and Total Factor Productivity: Evidence from China

Community social capital, managerial opportunistic behavior, and information uncertainty in IPO firms

IPO underpricing and overpricing and long-term firm performance in the Netherlands, United Kingdom, France, Sweden, and Italy: learning from three Dutch IPOs

IPO Over Subscription,Over Investment and Firm's Value

IPO Suspensions and Venture Capital Activity

The Efficient IPO Market Hypothesis: Theory and Evidence

Investment Banks' Entry into New IPO Markets and IPO Underpricing

Do IPO Firms Become Myopic?

Family Firm Governance and Financial Policy Choices in Newly Public Firms

Initial Public Offerings and the Local Economy: Evidence of Crowding out

Earnings Management and the Long-Run Market Performance of Initial Public Offerings

Earnings Management, IPO Underpricing, and Post-Issue Stock Performance of Chinese SMEs

How Costly is Follow-on Financing After Premature Going-public Decisions?

Long-run profitability deterioration after going public and the utilization of IPO proceeds

Economic Determinants and Consequences of the Proactive Disclosure of Internal Control Weaknesses and Remediation Progress in IPOs

Excess IPO Funds As an Imprint: an Imprinting Perspective of Acquisition Activity

Equity financing constraints and R&D investments: evidence from an IPO suspension in China

Competitive Effects of IPOs: Evidence from Chinese Listing Suspensions

Disclosure of Intended Use of Proceeds and Underpricing in Initial Public Offerings